The distribution of serologic specificities was comparable between ILD-onset and ILD-incident cases, but pSS-ILD patients with anti-Ro52+ autoantibodies exhibited a longer latency between pSS and ILD diagnosis compared to seronegative patients. This evidence concerns the gene TRIM21 and interstitial lung disease.